Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three Modalities of Treatment in Operable and Resectable Stage IIIA NSCLC
NCT00198367Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jan 2003
- Primary completion
- Jan 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, gemcitabine, vinorelbine, carboplatin, paclitaxel in non-small cell lung cancer (NSCLC), sponsored by Hospices Civils de Lyon. Started Jan 2003; status: completed.
02
Drugs
cisplatingemcitabinevinorelbinecarboplatinpaclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00198367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00198367.